Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

OBJECTIVES: To evaluate the degree of anticoagulation achieved with different enoxaparin dosing regimens used in obese and morbidly obese patients in a hospital setting in Jordan. METHODS: All obese adult patients who were prescribed enoxaparin for various indications were invited to participate in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahaineh, Linda, Edaily, Sahar M, Gharaibeh, Shadi F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965377/
https://www.ncbi.nlm.nih.gov/pubmed/29849468
http://dx.doi.org/10.2147/CPAA.S161599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965377/
https://www.ncbi.nlm.nih.gov/pubmed/29849468
http://dx.doi.org/10.2147/CPAA.S161599

Ejemplares similares